Bringing CRISPR to Clinical Reality

GEN Live: Genome Editing at the Turning Point—Bringing CRISPR to Clinical Reality

CRISPR is now a household term. Stories of genome editing therapies like Casgevy and Baby KJ have been headlines in our inboxes for years. Despite those cases, and the optimism they bring, genome editing has had significant challenges moving into the clinic.

This GEN Live show brings together a panel of leading experts to break down the latest advances, innovations, and challenges shaping genome editing. The discussion covers a lot of bases: CRISPR breakthroughs, emerging gene editing platforms, clinical trial milestones, regulatory shifts, access, off-target effects and safety considerations, and the growing role of large-scale population genomics in guiding precision therapies. Watch the event to learn more from our expert panelists and hear the questions submitted by our audience during the discussion.

Moderator: Julianna LeMieux, PhD, Deputy Editor in Chief, GEN

Panelist: Laura Sepp-Lorenzino, PhD, Former CSO, Intellia Therapeutics

Panelist: Shengdar Tsai, PhD, Associate Member, St. Jude Children’s Research Hospital

Originally produced and published by Genetic Engineering & Biotechnology News, a Sage publication. This program was sponsored by seqWell. View the official program and additional GEN content here.